CONFERENCE PROGRAM COMMITTEE
Chair: Bong-Min Yang PhD, Professor of Economics, School of Public Health, Seoul National University, Seoul, South Korea

RESEARCH REVIEW COMMITTEE
Gordon Liu PhD, Professor and Chair, Department of Health Economics and Management, Guanghau School of Management, Peking University, Beijing, China (Co-chair)
Urmila Mukund Thatte PhD, DNB, MD, MBBS, Professor and Head, Department of Clinical Pharmacology
Topiwala National Medical College, BYL Nair Charitable Hospital Mumbai Central, Mumbai, India (Co-chair)
Hiroyuki Sakamaki MBA, Dr Med Sci., Professor and Chair, Department of Clinical Economics, Faculty of Pharmacy, Meijo University, Nagoya, Japan (Co-chair)
Syed Mohamed Aljunid MD, MSc, PhD, FAMM, Professor of Health Economics, Head of Department of Community Health, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia (Co-chair)
Aamir Hameed MBBS, FCPS (Internal Medicine), FCPS (Cardiology), Assistant Professor & Consultant Cardiologist, Cardiology Section, Department of Medicine, The Aga Khan University, Karachi, Pakistan (Co-chair)
Sang-Cheol Bae MD, PhD, MPH, Professor and Director, The Hospital for Rheumatic Diseases, and Head, Section for  Clinical Epidemiology and Economics, Hanyang University, Seoul, South Korea (Co-chair)
Ming-Chin Yang DrPh, Associate Professor, School of Public Health, National Taiwan University, Taipei, Taiwan (Co-chair)
Surachat Ngorsuraches PhD. RPh, Head of Pharmacy Administration Department, Prince of Songkla University, Hatyai, Songkhla, Thailand (Co-chair)
Siew Hwa Ong MSc, Health Economics Manager, ID, Novartis Pharma AG, Basel, Switzerland
Dong-Churl Suh MBA, PhD, Associate Professor, College of Pharmacy, State University of New Jersey, Piscataway, NJ, USA
Peter K. Wong, PhD, MBA, MS, RPh, Vice President, Quality and Clinical Effectiveness, Mercy Health Partners, Southwest Ohio, Cincinnati, Ohio, USA
Jasmanda Hsiao-Hui Wu PhD, Associate Director, Outcomes Research, Ortho-McNeil Janssen Scientific Affairs, L.L.C., Johnson & Johnson, Titusville, NJ, USA

WORKSHOP REVIEW COMMITTEE
Wen Chen PhD, Professor and Associate Dean, School of Public Health, Fudan University, Shanghai, P.R. China (Co-chair)
Shunya Ikeda MD MS, DMSc, Professor of Public Health and Pharmacoeconomics, School of Pharmacy, International University of Health and Welfare, Tochigi, Japan (Co-chair)
Anwarul Hassan Gilani, PhD, National Professor and Director, Drug Discovery and Natural Products Research
Noor Mohammed Shamji Professor of Pharmacology, Dept. Biological and Biomedical Sciences, Aga Khan University Medical College, Karachi, Pakistan (Co-chair)
Shu-Chuen Li PhD, MS, MBA, Professor, Chair AND & Head, Discipline of Pharmacy & Experimental Pharmacology, School of Biomedical Sciences, University of Newcastle, Callaghan NSW 2308 Australia; And Visiting Professor, Department of Pharmacy National University of Singapore, Republic of Singapore (Co-chair)
Eui-Kyung Lee PhD, Professor, Graduate School of Clinical Pharmacy, Sookmyung Women’s University, Seoul, South Korea (Co-chair)
Lillian Yu-Jen Wang MS, Director, Taiwan Society for Pharmacoeconomics and Outcomes Research, Taipei, Taiwan (Co-chair)
Usa Chaikledkaew PhD, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand (Co-chair)
Alison Tan-Mulligan PhD, MBBS, Health Outcome & Epidemiology Manager, GlaxoSmithKline Pharmaceuticals (China) Investment Co. Ltd, Shanghai, P.R. China (Co-chair)
Ana Simoes Vaz das Neves MBA, Health Outcomes & Reimbursement Manager - Asia Pacific, Bayer Schering Pharma
Bayer (South East Asia) Pte Ltd, Singapore
Tini Q. Chau Nguyen Pharm D. HE Dipl., Health Outcomes Director, Sanofi-Aventis Asia-Pacific Region, Paris, France

ISSUE PANEL COMMITTEE
Eun-Young Bae PhD,Assistant Professor, College of Health Sciences, Sanji University, Wonju, South Korea
Carol Cheng, Chief Operating Officer, International Research-Based Pharmaceutical Manufactures Association (IRPMA), Taipei, Taiwan (Co-chair)
Vithaya Kulsomboon PhD, Associate Professor and Chair of Social Pharmacy Department, Chulalongkorn University, Bangkok, Thailand (Co-chair)
Eduardo P. Banzon MD, MSc, Senior Health Specialist, World Bank-Manila Office, Pasig City, Philippines (Co-chair)
Zhiqiang Guan MD, MPH, Director, Public Affairs and Policy, Pfizer, Inc, China, Beijing, China (Co-chair)
Hong Li PhD, MPH, Group Director, Outcomes Research, Asia Pacific, Bristol-Myers Squibb Company, Singapore (Co-chair)
Jim P. Doherty MSHA, PhD, GlaxoSmithKline, Global health Outcomes, Research Triangle Park, NC, USA
Sheldon Kong PhD, Executive Director, Global Outcomes Research, Reimbursement, and Health Technology Assessment (Global OR and HTA), Merck & Company, Inc., Whitehouse Station, NJ, USA
Eugene G Salole PhD, Senior Manager, Outcomes Research & Market Access (Asia), Pfizer Australia, Sydney, Australia
Mingliang Zhang PhD, Director, Health Economics, Pricing and Market Access, Asia Pacific and Japan, PGSM, Johnson & Johnson, Raritan, NJ, USA

SPECIAL SESSION COMMITTEE
Kenneth KC Lee JP, BSc(Pharm), MPhil, PhD, Professor, School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, P.R. China (Co-chair)
Jawahar S. Bapna PhD, MD, MB, Professor, Pharmaceutical Management, Indian Institute of Health Management Research, Jaipur, India (Co-chair)
Takashi Fukuda PhD, Associate Professor, Department of Health Economics and Epidemiology Research, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan (Co-chair)
Hye-Young Kang R.Ph, PhD, Assistant Professor of Health Policy and Administration, Graduate School of Public health, Yonsei University, Seoul, South Korea (Co-chair)
Hsiao-Yi Lin MD, FACR, Chief, Divisoin of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Taipei Veterans General Hospital, and Associate Professor, National Yang-Ming University, Taipei, Taiwan (Co-chair)
Kenneth hartigan-Go PhD, Executive Director, The Zuellig Foundation, Makati City, Philippine (Co-chair)
Charoen Treesak PhD, Head of the Center for Pharmaceutical Practice Study (CPPS), Faculty of Pharmacy, Srinakharinwirot University, Ongkharak, Nakhonnayok, Thailand (Co-chair)

SHORT COURSE COMMITTEE
Shanlian Hu MD, MSc, Professor, School of Public Health, Fudan University, Shanghai, P.R. China; Co-chair
Anita Kotwani PhD, Associate Professor, Department of Pharmacology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India (Co-chair)
Isao Kamae MD, DrPH, Professor and Chair, Graduate School of Health Management, Keio University, Tokyo, Japan (Co-chair)
Madeleine R. Valera MD, MScIH (Heidelberg), Officer-in-Charge, Health Finance Policy and Services Sector
Vice President, Quality Assurance Research and Policy Development Group, Philippine Health Insurance Corporation, Philippine Health Insurance Corporation, Pasig City, Philippines (Co-chair)
Sang-Il Lee PhD, MD, PhD, MPH, Professor, Department of Preventive Medicine, College of Medicine, University of Ulsan, Seoul, South Korea (Co-chair)
Tony Yen-Huei Tarn PhD, Senior Researcher, Health Technology Assessment Task Force, Center for Drug Evaluation, Taipei, Taiwan (Co-chair)
Nathorn Chaiyakunapruk PharmD, PhD, Associate Professor, Department of Pharmacy Practice, School of Pharmacy, Naresuan University, Phitsanulok, 65000, Thailand
Bruce Crawford MA, MPH, General Manager, Asia, Mapi Values, Tokyo, Japan
Christian Gericke, MD MPH MSc FACP, Professor and Chair in Public Health Policy, The University of Adelaide, Adelaide, Australia
Jeff J. Guo B. Pharm., PhD, Associate Professor, College of Pharmacy, University of Cincinnati Medical Center, Cincinnati, OH, USA